HCW Biologics reduces shareholder quorum requirement to 33-1/3%

HCW Biologics Inc.

Board approved amendment lowering quorum from majority to 33-1/3% of voting power.
Amendment effective April 28, 2026.
Quorum now defined as holders of 33-1/3% voting power present in person or by proxy.
Prior quorum required holders of a majority of outstanding voting power.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.